Skip to main content

Treatment Appoints Drew Zimmerman to its Board of Directors

By March 7, 2022 March 8th, 2022 No Comments

Vancouver, B.C. March 7, 2022 – International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939), a global healthcare technology company that has developed a next generation AI platform to help patients and caregivers around the world make better health decisions, is pleased to announce the appointment of Mr. Drew Zimmerman to the Board of Directors of the Company.

Mr. Zimmerman has been involved in public markets for ten years, eight of which were at a National brokerage firm as an Investment and Commodity Advisor before becoming a Derivatives Portfolio Manager. In that role Mr. Zimmerman has provided commodity and financial market analysis on BNN, Moneytalks Radio, HoweStreet Radio and at Investment Conferences. Mr. Zimmerman is a CFA® charter holder and holds a Bachelor of Commerce in International Business from the University of Victoria.